¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ ½ÉÆ÷Áö¾ö : 2024-02-03

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ ½ÉÆ÷Áö¾ö : 2024-02-03
±³À°ÀÏÀÚ : 2024-02-03
±³À°Àå¼Ò : ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç

±³À°ÁÖÁ¦ : 2024³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ ½ÉÆ÷Áö¾ö

ÁÖÃÖ±â°ü : ´ëÇѳ²¼º°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѺñ´¢È£¸£¸ó¿¬±¸ÇÐȸ

´ã´çÀÚ : ÇãÀçÀº
¿¬¶ôó : 02-6956-7967

À̸ÞÀÏ : gaonpco@gaonpco.com

±³À°Á¾·ù : ºñ´¢ÀÇÇаú, ÀÇ»çÇÐ, ÀÇÇб³À°

Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 20,000¿ø  

ºñ°í "Àü¹®ÀÇ: 20000¿ø (»çÀü, ÇöÀå µ¿ÀÏ)

Àü°øÀÇ, °£È£»ç, ¿¬±¸¿ø : 10000 (»çÀü, ÇöÀå µ¿ÀÏ)"  


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 10:50~11:05 Hormonal imbalance and Depression ÀÌÈ­¿µ(¼øõÇâÀÇ´ë Á¤½Å°Ç°­ÀÇÇаú)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 11:05~11:20 Hormonal imbalance and Obesity ¾È¼øÅÂ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 11:20~11:35 Hormonal imbalance and Osteoporosis ±èµ¿¼ö(°æÈñÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 11:35~11:50 Hormone therapy for Transgender patients ÀÌ»ó¹è(ÇѸ²ÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 11:50~12:00 ÆгÎÅäÀÇ ¹Î±Ç½Ä, ÇãÁ¤½Ä, ¹ÚÇöÁØ, ÀÌ¿ø±â(ÀÎÁ¦ÀÇ´ë, Á¦ÁÖÀÇ´ë, ºÎ»êÀÇ´ë, ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 12:50~13:05 Testosterone level and Premature ejacultation °¨¼ºÃ¶(°æ»óÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 13:05~13:20 Prevention of Late-onset male hypogonadism ½ÅÀ¯¼·(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 13:20~13:35 Hormonal imbalance and Infertility ±è´ë±Ù(Â÷ÀÇ°úÇдë)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 13:35~13:50 Hormonal imbalance and sexual dysfunction ÀÌÁØÈ£(À»ÁöÀÇ´ë)

Åä·Ð 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 13:50~14:00 ÆгÎÅäÀÇ ½ÅÈ«¼®, ±è¼±¿Á, ¼Û½ÂÈÆ, Á¶¹Îö, õ¿øÈñ(´ë±¸°¡Å縯ÀÇ´ë, Àü³²ÀÇ´ë, Â÷ÀÇ°úÇдë, ¼­¿ïÀÇ´ë, ´öõ¿äÆíÇѺñ´¢±â°úÀÇ¿ø)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 14:20~14:35 Testosterone replacement therapy in men with BPH or CP/CPPS ¹Úµ¿Áø(µ¿±¹ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 14:35~14:50 Testosterone replacement therapy for Testicular cancer ÃÖ¿ì¼®(°Ç±¹ÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 14:50~15:05 Role of androgen receptor in Urothelial carcinoma ÇÏÀ±¼®(°æºÏÀÇ´ë)

±³À°½Ã°£ 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 15:05~15:20 Current hormone treatment options for mHSPC and mCRPC ÃÖÁøºÀ(°¡Å縯ÀÇ´ë)

Åä·Ð 02¿ù 03ÀÏ ºÎ»ê´ëÇб³ º´¿ø ÀÀ±ÞÀÇ·á¼¾ÅÍ Eµ¿ 9Ãþ ´ë°­´ç 15:20~15:30 ÆгÎÅäÀÇ ·ùÁö°£, ÀÌÇйÎ, ¹Ú¹Î±¸, Á¤Çöö(ÀÎÇÏÀÇ´ë, ¼­¿ïÀÇ´ë, °í·ÁÀÇ´ë, ÇѸ²ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â ´ëÇѺñ´¢±âÈ£¸£¸ó¿¬±¸ÇÐȸ ½ÉÆ÷Áö¾ö : 2024-02-03""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽɺÎÀüÇÐȸ µðÁöÅÐÇコ ½ÉÆ÷Áö¾ö : 2024-02-03
´ÙÀ½±Û ´ëÇÑ°ñÀýÇÐȸ 2024 °ñ¹Ý°ñ °ñÀý ½ÉÆ÷Áö¾ö : 2024-02-03
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20913 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 75 2024-05-28
20912 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 79 2024-05-28
20911 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 61 2024-05-28
20910 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 64 2024-05-28
20909 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 62 2024-05-28
20908 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 73 2024-05-28
20907 ¼­¿ï 2024³â Á¦14ȸ °¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ ³»ºÐºñ³»°ú ¿¬¼ö°­Á : 2024-07-07 0 59 2024-05-28
20906 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø Á¤Çü¿Ü°ú 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-07-07 0 45 2024-05-28
20905 ¼­¿ï Á¦19Â÷ ´ëÇѸðÀ¯¼öÀ¯ÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-07-07 0 28 2024-05-28
20904 °æ±â Á¦2Â÷ ´ëÇѽŰæ¹æ»ç¼±¼ö¼úÇÐȸ Á¤±âÇмú´ëȸ : 2024-07-06 0 30 2024-05-28
20903 °æ±â Á¦ 5ȸ ¿À»ê½ÃÀÇ»çȸ Çмú´ëȸ : 2024-07-06 0 66 2024-05-28
20902 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦3ȸ ¾Æ»êµÎ°æºÎ Æ÷·³ : 2024-07-06 0 27 2024-05-28
20901 ¼­¿ï 2024³â Á¦2ȸ °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø ¼øȯ±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-06 0 47 2024-05-28
20900 ¼­¿ï ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day3) : 2024-07-06 0 54 2024-05-28
20899 ¼­¿ï ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ 2024³â ÇÏ°è NeurocrItical Care Essence (NICE) ¾ÆÄ«µ¥¹Ì : 2024-07-06 0 20 2024-05-28
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷